Sodium-glucose cotransporter 2 (SGLT2) inhibitors used for the treatment of type 2 diabetes, and for heart failure, are associated with a nearly threefold increased risk for diabetic ketoacidosis (DKA ...

Diabetic ketoacidosis (DKA) is a complication of diabetes. It can occur when the body does not have enough insulin to use sugar as energy. Instead, it breaks down fat and produces ketones. This can ...

Researchers show that using continuous glucose monitors can help measure glucose accurately during DKA and potentially prevent ICUs from being overwhelmed. Diabetic ketoacidosis is a common severe ...

Cerebral edema in diabetic ketoacidosis (DKA-CE) occurs primarily in children and can develop during DKA therapy. The treatment factors contributing to DKA-CE remain elusive. Our objectives were to ...

Lactic acidosis occurs when the body produces too much lactic acid and cannot metabolize it quickly enough. The condition can be a medical emergency. The onset of lactic acidosis might be rapid and ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the use of ...

When cells cannot access glucose as an energy source, the body turns to alternative fuels, such as fat. This process produces substances known as ketones, which can accumulate in blood and urine. In ...

In a recent study, published in The Lancet Diabetes and Endocrinology, researchers evaluated trends in diabetic ketoacidosis (DKA) prevalence at pediatric type 1 diabetes mellitus (T1D) diagnosis ...